News Releases
Science & Technology International® Launches
the UltraSightHDTM Digital Colposcopy System, revolutionizing Colposcopy and the Early Detection of Cervical Cancer
“The UltraSightHD Digital Colposcope is the state-of-the-art in the field of colposcopy”
—- Julie Liss, Women Veterans Program Manager
Science & Technology International, Inc. announced today the global launch of its UltraSightHDTM Digital Colposcopy System with ImageSenseTM diagnostic enhancement technology. The FDA cleared and CE Mark certified state-of-the-art system will revolutionize colposcopy through its high-definition imaging, clinical workflow management software and seamless integration with electronic health records systems. Based on proprietary technologies, the UltraSightHD system enables physicians the ability to capture archive quality images with unparalleled clarity and easily annotate clinical impressions during an exam through an intuitive touch screen toolbox.
“Today’s announcement will have a profound impact on women’s health by providing healthcare professionals with 21st century visual intelligence to identify and detect suspicious lesions of the cervix,” said Nicholas J. Susner, President and CEO of Science & Technology International, Inc., “Our UltraSightHD system brings significant value added to the healthcare industry, creating the opportunity for improved clinical outcomes through its integrated telemedicine and electronic health record functionality.”
Cervical Cancer is the second most common cancer among women worldwide, with an estimated 493,000 new cases and 273,000 deaths per year. These statistics are troubling since, when detected early, cervical neoplasia is almost always curable.